CardieX Limited (CDX.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -6.76 Million AUD | 64.51% |
| 2023 | -19.06 Million AUD | -67.47% |
| 2022 | -11.38 Million AUD | -105.27% |
| 2021 | -5.54 Million AUD | -67.01% |
| 2020 | -3.32 Million AUD | -11.45% |
| 2019 | -2.97 Million AUD | -0.61% |
| 2018 | -2.96 Million AUD | 32.14% |
| 2017 | -4.36 Million AUD | 9.2% |
| 2016 | -4.8 Million AUD | -233.7% |
| 2015 | -1.44 Million AUD | 45.93% |
| 2014 | -2.66 Million AUD | -197.42% |
| 2013 | 2.73 Million AUD | 237.7% |
| 2012 | -1.98 Million AUD | 35.56% |
| 2011 | -3.08 Million AUD | -152.54% |
| 2010 | -1.22 Million AUD | 27.87% |
| 2009 | -1.69 Million AUD | 55.4% |
| 2008 | -3.79 Million AUD | 26.82% |
| 2007 | -5.18 Million AUD | -29.41% |
| 2006 | -4 Million AUD | -48.55% |
| 2005 | -2.69 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -3.78 Million AUD | -569.04% |
| 2024 Q4 | -3.78 Million AUD | 0.0% |
| 2024 Q2 | 807.25 Thousand AUD | 100.0% |
| 2024 FY | -7.63 Million AUD | 59.93% |
| 2024 Q1 | 403.62 Thousand AUD | 103.95% |
| 2023 FY | -19.06 Million AUD | -67.47% |
| 2023 Q4 | -10.21 Million AUD | -100.0% |
| 2023 Q2 | -8.67 Million AUD | -100.0% |
| 2023 Q1 | -4.33 Million AUD | 35.07% |
| 2023 Q3 | -5.1 Million AUD | 41.1% |
| 2022 FY | -11.38 Million AUD | -105.27% |
| 2022 Q4 | -6.67 Million AUD | -151.08% |
| 2022 Q3 | -2.65 Million AUD | 48.17% |
| 2022 Q2 | -5.13 Million AUD | -58.14% |
| 2022 Q1 | -3.24 Million AUD | 6.5% |
| 2021 Q2 | -2.07 Million AUD | -100.0% |
| 2021 Q1 | -1.03 Million AUD | 23.45% |
| 2021 Q4 | -3.47 Million AUD | -123.54% |
| 2021 Q3 | -1.55 Million AUD | 25.16% |
| 2021 FY | -5.54 Million AUD | -67.01% |
| 2020 Q2 | -1.96 Million AUD | -100.0% |
| 2020 FY | -3.32 Million AUD | -11.45% |
| 2020 Q4 | -1.35 Million AUD | -100.0% |
| 2020 Q3 | -677.51 Thousand AUD | 65.53% |
| 2020 Q1 | -982.69 Thousand AUD | 39.11% |
| 2019 Q2 | -682.69 Thousand AUD | 0.0% |
| 2019 Q4 | -1.61 Million AUD | -100.0% |
| 2019 FY | -2.97 Million AUD | -0.61% |
| 2019 Q1 | -682.69 Thousand AUD | 27.37% |
| 2019 Q3 | -806.94 Thousand AUD | -18.2% |
| 2018 Q4 | -939.9 Thousand AUD | 0.0% |
| 2018 Q3 | -939.9 Thousand AUD | -73.83% |
| 2018 FY | -2.96 Million AUD | 32.14% |
| 2018 Q2 | -540.71 Thousand AUD | 0.0% |
| 2018 Q1 | -540.71 Thousand AUD | 56.66% |
| 2017 FY | -4.36 Million AUD | 9.2% |
| 2017 Q2 | -934.04 Thousand AUD | 0.0% |
| 2017 Q1 | -934.04 Thousand AUD | 25.51% |
| 2017 Q4 | -1.24 Million AUD | 0.0% |
| 2017 Q3 | -1.24 Million AUD | -33.58% |
| 2016 Q3 | -1.25 Million AUD | -9.14% |
| 2016 Q4 | -1.25 Million AUD | 0.0% |
| 2016 Q2 | -1.14 Million AUD | 0.0% |
| 2016 Q1 | -1.14 Million AUD | -55.1% |
| 2016 FY | -4.8 Million AUD | -233.7% |
| 2015 FY | -1.44 Million AUD | 45.93% |
| 2015 Q4 | -740.81 Thousand AUD | 0.0% |
| 2015 Q3 | -740.81 Thousand AUD | -3674.5% |
| 2015 Q2 | 20.72 Thousand AUD | -0.0% |
| 2015 Q1 | 20.72 Thousand AUD | 102.43% |
| 2014 Q4 | -852.32 Thousand AUD | 0.0% |
| 2014 Q1 | -479.42 Thousand AUD | -305.88% |
| 2014 FY | -2.66 Million AUD | -197.42% |
| 2014 Q2 | -479.42 Thousand AUD | 0.0% |
| 2014 Q3 | -852.32 Thousand AUD | -77.78% |
| 2013 Q3 | 232.86 Thousand AUD | -79.47% |
| 2013 Q2 | 1.13 Million AUD | -0.0% |
| 2013 Q4 | 232.86 Thousand AUD | 0.0% |
| 2013 FY | 2.73 Million AUD | 237.7% |
| 2013 Q1 | 1.13 Million AUD | 328.48% |
| 2012 Q2 | -496.37 Thousand AUD | 35.56% |
| 2012 Q4 | -496.37 Thousand AUD | 0.0% |
| 2012 Q3 | -496.37 Thousand AUD | 0.0% |
| 2012 Q1 | -770.27 Thousand AUD | 0.0% |
| 2012 FY | -1.98 Million AUD | 35.56% |
| 2011 Q1 | -305.01 Thousand AUD | 0.0% |
| 2011 Q4 | -770.27 Thousand AUD | 0.0% |
| 2011 FY | -3.08 Million AUD | -152.54% |
| 2011 Q3 | -770.27 Thousand AUD | 0.0% |
| 2011 Q2 | -770.27 Thousand AUD | -152.54% |
| 2010 Q2 | -305.01 Thousand AUD | 27.87% |
| 2010 Q3 | -305.01 Thousand AUD | 0.0% |
| 2010 Q1 | -422.85 Thousand AUD | 0.0% |
| 2010 FY | -1.22 Million AUD | 27.87% |
| 2010 Q4 | -305.01 Thousand AUD | 0.0% |
| 2009 Q2 | -422.85 Thousand AUD | 55.4% |
| 2009 Q4 | -422.85 Thousand AUD | 0.0% |
| 2009 Q1 | -948.18 Thousand AUD | 0.0% |
| 2009 Q3 | -422.85 Thousand AUD | 0.0% |
| 2009 FY | -1.69 Million AUD | 55.4% |
| 2008 Q1 | -1.29 Million AUD | 0.0% |
| 2008 Q2 | -948.18 Thousand AUD | 26.82% |
| 2008 Q3 | -948.18 Thousand AUD | 0.0% |
| 2008 FY | -3.79 Million AUD | 26.82% |
| 2008 Q4 | -948.18 Thousand AUD | 0.0% |
| 2007 Q2 | -1.29 Million AUD | -29.41% |
| 2007 Q3 | -1.29 Million AUD | 0.0% |
| 2007 Q4 | -1.29 Million AUD | 0.0% |
| 2007 FY | -5.18 Million AUD | -29.41% |
| 2007 Q1 | -1 Million AUD | 0.0% |
| 2006 Q3 | -1 Million AUD | 0.0% |
| 2006 Q1 | -674 Thousand AUD | 0.0% |
| 2006 FY | -4 Million AUD | -48.55% |
| 2006 Q2 | -1 Million AUD | -48.55% |
| 2006 Q4 | -1 Million AUD | 0.0% |
| 2005 Q4 | -674 Thousand AUD | 0.0% |
| 2005 Q2 | -674 Thousand AUD | 0.0% |
| 2005 FY | -2.69 Million AUD | 0.0% |
| 2005 Q3 | -674 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 81.196% |
| Adherium Limited | -10.22 Million AUD | 33.83% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 30.599% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 1.204% |
| Anteris Technologies Ltd | -67.33 Million AUD | 89.952% |
| Control Bionics Limited | -5.91 Million AUD | -14.4% |
| Compumedics Limited | -338 Thousand AUD | -1901.587% |
| Cochlear Limited | 356.8 Million AUD | 101.896% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -116.343% |
| Cyclopharm Limited | -4.7 Million AUD | -43.919% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -147.851% |
| Nova Eye Medical Limited | -8.79 Million AUD | 23.033% |
| HeraMED Limited | -6.78 Million AUD | 0.27% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 70.099% |
| ImpediMed Limited | -19.79 Million AUD | 65.814% |
| InhaleRx Limited | -1.44 Million AUD | -368.752% |
| LBT Innovations Limited | -3.74 Million AUD | -80.892% |
| Micro-X Limited | -9.76 Million AUD | 30.718% |
| Neurotech International Limited | -5.06 Million AUD | -33.459% |
| OncoSil Medical Limited | -11.91 Million AUD | 43.213% |
| PolyNovo Limited | 5.26 Million AUD | 228.595% |
| Respiri Limited | -7.12 Million AUD | 5.104% |
| SomnoMed Limited | -12.24 Million AUD | 44.735% |
| Universal Biosensors, Inc. | -6.74 Million AUD | -0.353% |
| Uscom Limited | -2.07 Million AUD | -226.081% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -33.616% |